STOCK TITAN

Houlihan Lokey, Inc. - $HLI STOCK NEWS

Welcome to our dedicated page for Houlihan Lokey news (Ticker: $HLI), a resource for investors and traders seeking the latest updates and insights on Houlihan Lokey stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Houlihan Lokey's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Houlihan Lokey's position in the market.

Rhea-AI Summary

Houlihan Lokey, Inc. announced Erik Kistler as the new Managing Director of the Healthcare Group, covering healthcare retail multi-site, physician practices, and pharma services. With vast experience in the field, Kistler's addition is seen as a strategic move to further strengthen the firm's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.12%
Tags
none
-
Rhea-AI Summary
Houlihan Lokey (NYSE:HLI) expands its software coverage capabilities by hiring Ryan Lund as Co-Head of U.S. Technology and Global Co-Head of Software, along with Vikram Kaushik and Ted Sullivan. The move aims to strengthen the software team and enhance advisory services for technology companies amidst rapid industry changes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
management
-
Rhea-AI Summary
Houlihan Lokey, Inc. (NYSE:HLI) announced the release date for its fourth quarter and full year results for the fiscal year 2024. The results will be disclosed on May 8, 2024, after the market closes, with a conference call following the next day. The call will feature key executives discussing the financial results and business performance, with a Q&A session for analysts and investors. Participants can join via telephone or webcast, with replay options available for both formats.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
Rhea-AI Summary
Houlihan Lokey, Inc. (NYSE:HLI) welcomes Dr. Ashish Patel as a Managing Director in its Capital Markets Group to enhance equity private placement capabilities in Europe. Dr. Patel brings extensive experience in growth capital solutions, particularly in healthcare, life sciences, climate tech, and enterprise software. His appointment signifies Houlihan Lokey's commitment to providing tailored equity solutions for European companies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.48%
Tags
none
-
Rhea-AI Summary
Houlihan Lokey, Inc. (NYSE:HLI) welcomes Michael Schwartz as a Managing Director in its Capital Markets Group in New York. Schwartz brings expertise from Lazard and Cowen and Company to enhance private capital financing efforts. The firm emphasizes delivering successful outcomes to clients globally amidst the growing private capital market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
none
-
Rhea-AI Summary
Houlihan Lokey, Inc. expands its Private Funds Group with the addition of a team of four managing directors from Greenhill & Co. to bolster its U.S. Primary practice. Led by industry veteran Tom Donovan, the team brings extensive experience in private capital raising. This move follows the acquisition of Triago Management Development, reinforcing Houlihan Lokey's presence in the private capital advisory space.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
management
Rhea-AI Summary
Abhishek Jain, a Managing Director, has joined Houlihan Lokey, Inc. (NYSE:HLI) to enhance the firm's industrials due diligence capabilities. With nearly two decades of experience in financial due diligence, Mr. Jain will focus on the industrials sector, having worked in various sectors like business services, technology, and consumer sectors. His expertise will contribute to the growth of Houlihan Lokey's Transaction Advisory Services (TAS) practice.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.02%
Tags
none
-
Rhea-AI Summary
Houlihan Lokey, Inc. (NYSE:HLI) welcomes Val Shapiro as a Managing Director in the Financial Sponsors Group to enhance credit coverage efforts. Shapiro's extensive experience in credit investing and distressed situations will benefit clients. Houlihan Lokey's team-oriented approach and global presence position them as a leading advisor to alternative capital providers.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.52%
Tags
none
-
Rhea-AI Summary
Houlihan Lokey, Inc. (NYSE:HLI) appoints Rafael Pereira as Senior Advisor to aid in Brazil expansion. Pereira, with extensive tech experience, co-founded Brazil's leading FinTech, raising $1 billion. His collaboration with Houlihan Lokey's Technology and FinTech groups aims to support local companies in various growth stages.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.15%
Tags
management
Rhea-AI Summary
Houlihan Lokey, Inc. (NYSE:HLI) welcomes Brent Shepherd as a Managing Director in Chicago, enhancing their Healthcare Capital Markets team. With 24 years of experience at Capital One's Healthcare Banking and Lending unit, Mr. Shepherd brings valuable expertise in financing acquisitions for financial sponsors. His addition aims to strengthen Houlihan Lokey's ability to cater to the growing capital needs of healthcare clients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.01%
Tags
none
Houlihan Lokey, Inc.

NYSE:HLI

HLI Rankings

HLI Stock Data

9.28B
50.58M
0.13%
107.19%
1.9%
Investment Banking and Securities Dealing
Finance and Insurance
Link
United States of America
LOS ANGELES

About HLI

houlihan lokey (nyse: hli) is a global investment bank with expertise in mergers and acquisitions, capital markets, valuation, financial restructuring, and strategic consulting. the firm serves corporations, institutions, and governments worldwide with offices in the united states, europe, and the asia-pacific region. independent advice and intellectual rigor are hallmarks of our commitment to client success across our advisory services. houlihan lokey is ranked as the no. 1 m&a advisor for u.s. transactions under $5 billion, the no. 1 m&a fairness opinion advisor for u.s. transactions over the past 10 years, and the no. 1 global restructuring advisor, according to thomson reuters. for more information, please visit www.hl.com.